News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,878 Results
Type
Article (100)
Press Release (1778)
Section
Business (526)
Deals (103)
Drug Delivery (1)
Drug Development (63)
FDA (64)
Job Trends (18)
News (778)
Policy (104)
Tag
Academia (2)
Alliances (120)
Alzheimer's disease (1)
Approvals (69)
Artificial intelligence (2)
Automation (1)
Bankruptcy (1)
Best Places to Work (11)
Biosimilars (9)
Cancer (3)
CAR-T (2)
Cell therapy (4)
Clinical research (54)
Collaboration (3)
COVID-19 (3)
C-suite (3)
Data (4)
Depression (4)
Diagnostics (14)
Drug pricing (1)
Earnings (174)
Events (108)
Executive appointments (4)
FDA (79)
Funding (1)
Gene therapy (4)
GLP-1 (3)
Government (19)
Guidances (2)
Healthcare (91)
IgA nephropathy (5)
Immunology and inflammation (1)
Infectious disease (3)
Intellectual property (1)
IPO (32)
Job creations (8)
Layoffs (2)
Legal (31)
Lymphoma (1)
Manufacturing (4)
Medical device (41)
Medtech (42)
Mergers & acquisitions (72)
Metabolic disorders (1)
Neuroscience (5)
NextGen: Class of 2026 (12)
Non-profit (11)
Patents (2)
Patient recruitment (1)
People (225)
Phase 1 (11)
Phase 2 (23)
Phase 3 (33)
Pipeline (14)
Postmarket research (4)
Preclinical (6)
Psychedelics (1)
Real estate (17)
Regulatory (71)
Research institute (4)
Startups (13)
The Weekly (1)
Weight loss (1)
Date
Last 7 days (1)
Last 30 days (2)
Last 365 days (67)
2026 (6)
2025 (68)
2024 (93)
2023 (83)
2022 (301)
2021 (254)
2020 (242)
2019 (158)
2018 (98)
2017 (76)
2016 (79)
2015 (76)
2014 (41)
2013 (43)
2012 (42)
2011 (45)
2010 (41)
Location
Africa (1)
Asia (54)
Australia (10)
California (11)
Canada (5)
Colorado (1)
Connecticut (1)
Delaware (1)
Europe (426)
Illinois (30)
Japan (1)
Maryland (1)
Massachusetts (7)
New Hampshire (1)
New Jersey (8)
New York (9)
North Carolina (2)
Northern California (5)
Ohio (1)
Pennsylvania (2)
Puerto Rico (1)
Southern California (5)
Tennessee (1)
Texas (1)
United States (77)
1,878 Results for "fresenius kabi".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fresenius Kabi, TQ Therapeutics Announce Cell Therapy Technology Agreement
January 15, 2026
·
5 min read
Press Releases
Fresenius Kabi Introduces New Presentation of Otulfi® (ustekinumab-aauz), a Biosimilar to Stelara®
January 6, 2026
·
12 min read
Press Releases
Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection Stable at Room Temperature
December 19, 2025
·
5 min read
Press Releases
FDA Grants Interchangeable Designation to Fresenius Kabi’s Biosimilars Conexxence® and Bomyntra® (denosumab-bnht)
October 29, 2025
·
4 min read
Press Releases
Fresenius Kabi Introduces Dalbavancin for Injection (for single-dose regimen use only)
November 24, 2025
·
5 min read
Press Releases
Fresenius Kabi’s Adaptive Nomogram used on Aurora Xi Plasmapheresis System Now Operating Nationwide at BioLife Plasma Centers
November 12, 2025
·
3 min read
Press Releases
Fresenius Kabi Receives Two Major Awards for Supply and Service Excellence from Vizient®
September 25, 2025
·
3 min read
Press Releases
CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code for Conexxence® and Bomyntra® (denosumab-bnht)
September 29, 2025
·
5 min read
Press Releases
Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016
August 5, 2025
·
4 min read
Press Releases
FDA Grants Interchangeable Designation to Fresenius Kabi’s biosimilar Otulfi® (ustekinumab-aauz)
May 19, 2025
·
12 min read
1 of 188
Next
